Novel Method for Detection of Ovarian Cancer Might Launch Soon
Ovarian cancer is considered to be the most difficult to detect in kinds of cancers. It is difficult to note or detect at early cancer stage, if pain occurs, people might treat it as other symptoms as often been mistaken for other diseases. This makes cancer prevention and control very difficult. Data show that the survival rate of early-stage ovarian cancer is about 90%, while advanced-stage drops to less than 30%.
Now a new detection method will be possible to overcome this difficulty.
In previous studies, researchers have noticed a blood protein called CA125 whose expression level may be associated with ovarian cancer. However, the indicator alone may not be reliable. According to CA125 protein level, the researchers divided subjects into high-risk, medium-risk and low-risk groups. Among high-risk group, researchers can immediately check for the presence of tumor. The results show that the 10 women are in early ovarian cancer stage. This suggests that early detection of ovarian cancer is theoretically feasible.
Another large study conducted in the UK may give us answers to this question. The study will track 50,000 women and the study is expected to be completed in 2015. At that time, people perhaps can be saved from ovarian cancer with this detection method.
Being a leading biotech company, Creative BioMart provides quality Human Cancer Antigen 125 for researchers’ protein binding; hydrogen ion transmembrane transporter activity studies etc. Contact us if you have needs.